GeneDx Holdings
98 hedge funds and large institutions have $138M invested in GeneDx Holdings in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 19 closing their positions.
4,647% more call options, than puts
Call options by funds: $1.52M | Put options by funds: $32K
3% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 31
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.03% less ownership
Funds ownership: 1.29% → 1.26% (-0.03%)
12% less funds holding
Funds holding: 111 → 98 (-13)
31% less capital invested
Capital invested by funds: $202M → $138M (-$63.5M)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$2.52M |
| 2 |
Goldman Sachs
New York
|
+$1.62M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.02M |
| 4 |
BlackRock
New York
|
+$975K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$454K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.98M |
| 2 |
DM
Deerfield Management
New York
|
-$2.6M |
| 3 |
GS
Gagnon Securities
New York
|
-$1.12M |
| 4 |
GA
Gagnon Advisors
New York
|
-$1.03M |
| 5 |
Renaissance Technologies
New York
|
-$999K |
WGS Hedge Fund Activity: Q3 2022 in Review
98 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q3 2022, worth a combined $138M — down 31% from $202M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of WGS and 7 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 32 added.
The largest buyer was Oracle Investment Management, adding an estimated $2.52M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.98M.
- 98 institutional investors held GeneDx Holdings (WGS) as of Q3 2022, down from 111 in Q2 2022.
- Funds reported $138M of GeneDx Holdings stock for Q3 2022, down 31% quarter-over-quarter.
- 7 funds opened new GeneDx Holdings positions in Q3 2022 and 19 closed out, a net change of -12 holders.
- The largest GeneDx Holdings buyer in Q3 2022 was Oracle Investment Management, an estimated $2.52M added.
- The largest GeneDx Holdings seller in Q3 2022 was D.E. Shaw & Co, an estimated $2.98M sold.
Based on aggregated 13F filings for Q3 2022.